Literature DB >> 15970930

The phenotypes of bipolar disorder: relevance for genetic investigations.

G M MacQueen1, T Hajek, M Alda.   

Abstract

The search for susceptibility genes for bipolar disorder (BD) depends on appropriate definitions of the phenotype. In this paper, we review data on diagnosis and clinical features of BD that could be used in genetic studies to better characterize patients or to define homogeneous subgroups. Clinical symptoms, long-term course, comorbid conditions, and response to prophylactic treatment may define groups associated with more or less specific loci. One such group is characterized by symptoms of psychosis and linkage to 13q and 22q. A second group includes mainly bipolar II patients with comorbid panic disorder, rapid mood switching, and evidence of chromosome 18 linkage. A third group comprises typical BD with an episodic course and favourable response to lithium prophylaxis. Reproducibility of cognitive deficits across studies raises the possibility of using cognitive profiles as endophenotypes of BD, with deficits in verbal explicit memory and executive function commonly reported. Brain imaging provides a more ambiguous data set consistent with heterogeneity of the illness.

Entities:  

Mesh:

Year:  2005        PMID: 15970930     DOI: 10.1038/sj.mp.4001701

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  24 in total

1.  Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study.

Authors:  Kaan Yucel; Margaret C McKinnon; Valerie H Taylor; Kathryn Macdonald; Martin Alda; L Trevor Young; Glenda M MacQueen
Journal:  Psychopharmacology (Berl)       Date:  2007-08-20       Impact factor: 4.530

Review 2.  Brain functional domains inform therapeutic interventions in attention-deficit/hyperactivity disorder and pediatric bipolar disorder.

Authors:  Alessandra M Passarotti; Mani N Pavuluri
Journal:  Expert Rev Neurother       Date:  2011-06       Impact factor: 4.618

3.  Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: meta-analysis.

Authors:  Tomas Hajek; Miloslav Kopecek; Cyril Höschl
Journal:  World J Biol Psychiatry       Date:  2011-07-04       Impact factor: 4.132

4.  Staging model raises fundamental questions about the nature of bipolar disorder.

Authors:  Martin Alda; Flavio Kapczinski
Journal:  J Psychiatry Neurosci       Date:  2016-08       Impact factor: 6.186

5.  The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration.

Authors:  Jared W Young; Andrew K L Goey; Arpi Minassian; William Perry; Martin P Paulus; Mark A Geyer
Journal:  Pharmacol Biochem Behav       Date:  2010-04-02       Impact factor: 3.533

6.  Pathological amygdala activation during working memory performance: Evidence for a pathophysiological trait marker in bipolar affective disorder.

Authors:  Oliver Gruber; Heike Tost; Ilona Henseler; Christine Schmael; Harald Scherk; Gabriele Ende; Matthias Ruf; Peter Falkai; Marcella Rietschel
Journal:  Hum Brain Mapp       Date:  2010-01       Impact factor: 5.038

7.  Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Authors:  Alessio Squassina; Mirko Manchia; Maria Del Zompo
Journal:  Hum Genomics Proteomics       Date:  2010-08-03

8.  Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.

Authors:  Kathleen R Merikangas; Hagop S Akiskal; Jules Angst; Paul E Greenberg; Robert M A Hirschfeld; Maria Petukhova; Ronald C Kessler
Journal:  Arch Gen Psychiatry       Date:  2007-05

9.  Neurocognition in bipolar disorder and juvenile bipolar disorder.

Authors:  Catherine M Cahill; Garry Walter; Gin S Malhi
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-08

10.  Lithium: a key to the genetics of bipolar disorder.

Authors:  Cristiana Cruceanu; Martin Alda; Gustavo Turecki
Journal:  Genome Med       Date:  2009-08-19       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.